Curefox Healthcare Profile
Key Indicators
- Authorised Capital ₹ 3.20 Cr
as on 19-12-2024
- Paid Up Capital ₹ 3.20 Cr
as on 19-12-2024
- Company Age 3 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 29.00 Cr
as on 19-12-2024
- Revenue %
(FY 2022)
- Profit -214.61%
(FY 2022)
- Net Worth -0.27%
(FY 2022)
- Total Assets 45.00%
(FY 2022)
About Curefox Healthcare
The Corporate was formerly known as Curefox Medical Devices Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.20 Cr and a paid-up capital of Rs 3.20 Cr.
The company currently has active open charges totaling ₹29.00 Cr.
Sumit Garala, Ashish Kotadiya, Bharatbhai Ranparia, and One other member serve as directors at the Company.
- CIN/LLPIN
U33209GJ2021PTC119698
- Company No.
119698
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jan 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Curefox Healthcare?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumit Garala  | Director | 22-Jan-2021 | Current |
| Ashish Kotadiya | Director | 22-Jan-2021 | Current |
| Bharatbhai Ranparia | Director | 22-Jan-2021 | Current |
| Hitesh Gaudani | Director | 28-Jul-2021 | Current |
Financial Performance of Curefox Healthcare.
Curefox Healthcare Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 214.61% decrease in profit. The company's net worth dipped by a decrease of 0.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Curefox Healthcare?
Unlock access to Curefox Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Salus Products Private LimitedActive 4 years 5 monthsSumit Garala and Ashish Kotadiya are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 14 Sep 2023 | ₹29.00 Cr | Open |
How Many Employees Work at Curefox Healthcare?
Curefox Healthcare has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Curefox Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curefox Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
